statistiche ricercatore

CLEMENTI, MASSIMO

Distribuzione geografica

Continente	#
NA - Nord America	1.971
EU - Europa	1.622
AS - Asia	1.559
SA - Sud America	168
AF - Africa	31
OC - Oceania	3
Totale	5.354

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	1.896
IT - Italia	1.021
SG - Singapore	682
CN - Cina	362
HK - Hong Kong	247
BR - Brasile	149
VN - Vietnam	126
GB - Regno Unito	109
FR - Francia	90
DE - Germania	89
FI - Finlandia	81
IE - Irlanda	76
RU - Federazione Russa	74
CA - Canada	37
IN - India	37
MX - Messico	35
JP - Giappone	18
BD - Bangladesh	16
NL - Olanda	14
PL - Polonia	13
ES - Italia	11
IQ - Iraq	11
TR - Turchia	11
AT - Austria	10
SA - Arabia Saudita	10
KE - Kenya	8
ZA - Sudafrica	8
AR - Argentina	7
BE - Belgio	7
LT - Lituania	6
NG - Nigeria	6
CH - Svizzera	5
AE - Emirati Arabi Uniti	4
JO - Giordania	4
SE - Svezia	4
UA - Ucraina	4
AZ - Azerbaigian	3
MA - Marocco	3
PK - Pakistan	3
UZ - Uzbekistan	3
AU - Australia	2
CL - Cile	2
CO - Colombia	2
EG - Egitto	2
ID - Indonesia	2
IL - Israele	2
KR - Corea	2
KZ - Kazakistan	2
LB - Libano	2
PE - Perù	2
PH - Filippine	2
QA - Qatar	2
VE - Venezuela	2
BG - Bulgaria	1
BH - Bahrain	1
BO - Bolivia	1
BY - Bielorussia	1
BZ - Belize	1
CG - Congo	1
CI - Costa d'Avorio	1
CR - Costa Rica	1
DK - Danimarca	1
EC - Ecuador	1
ET - Etiopia	1
GE - Georgia	1
GN - Guinea	1
GR - Grecia	1
IR - Iran	1
KG - Kirghizistan	1
MD - Moldavia	1
MY - Malesia	1
NC - Nuova Caledonia	1
OM - Oman	1
PS - Palestinian Territory	1
PY - Paraguay	1
RS - Serbia	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
SY - Repubblica araba siriana	1
TT - Trinidad e Tobago	1
UY - Uruguay	1
Totale	5.354

Salva come PNG Salva come JPEG

Città	#
Milan	681
San Jose	473
Singapore	372
Ashburn	268
Hong Kong	244
Chicago	168
Beijing	146
The Dalles	120
Dallas	97
Council Bluffs	87
Boardman	86
Dublin	76
London	75
Helsinki	71
Lauterbourg	71
Rome	60
Los Angeles	58
Ho Chi Minh City	41
Hanoi	32
Mexico City	27
Munich	27
Washington	27
New York	26
Ogden	26
Frankfurt am Main	21
Santa Clara	21
Brooklyn	20
Seattle	20
Orem	18
Tokyo	17
Varese	17
Chennai	13
Como	13
San Francisco	13
Warsaw	13
Toronto	12
Montreal	10
Nuremberg	10
São Paulo	10
Guangzhou	9
Shanghai	9
Atlanta	8
Nairobi	8
Shenzhen	8
Vancouver	8
Vienna	8
Amsterdam	7
Boston	7
Brussels	7
Denver	7
Pune	7
Abuja	6
Ankara	6
Da Nang	6
Johannesburg	6
New Delhi	6
Phoenix	6
Pittsburgh	6
Poplar	6
Berlin	5
Dhaka	5
Düsseldorf	5
Falkenstein	5
Haiphong	5
Hangzhou	5
Magnago	5
Querétaro	5
Rio de Janeiro	5
Amman	4
Baghdad	4
Bari	4
Belo Horizonte	4
Bodio Lomnago	4
Cernusco sul Naviglio	4
Chiswick	4
Jeddah	4
Mumbai	4
Riyadh	4
Salt Lake City	4
Sulmona	4
Turku	4
West Jordan	4
Blumenau	3
Campinas	3
Detroit	3
Fortaleza	3
Goiânia	3
Houston	3
Hải Dương	3
Lappeenranta	3
Manchester	3
Miami	3
Paris	3
Stockholm	3
Thái Nguyên	3
Topeka	3
Assago	2
Baltimore	2
Bismarck	2
Biên Hòa	2
Totale	3.879

Salva come PNG Salva come JPEG

Nome	#
A biologically-validated HCV E1E2 heterodimer structural model	117
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes	109
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine	103
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs	103
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes	102
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)	99
A case of psoriatic arthritis triggered by SARS-CoV-2 infection	98
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19	97
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases	97
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools	96
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections	93
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses	93
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients	93
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2	90
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein	89
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections	89
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes	88
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies	87
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens	85
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion?	84
Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study	84
Answer to photo quiz: Streptococcus pneumoniae	82
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies	82
A human stem cell-derived neurosensory–epithelial circuitry on a chip to model herpes simplex virus reactivation	82
Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference	81
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches	80
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study	79
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects	78
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome	78
The interferon landscape along the respiratory tract impacts the severity of COVID-19	77
Viral respiratory pathogens and lung Injury	74
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice	73
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials	73
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?	73
Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro	71
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes	71
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital	71
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII)	70
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients	70
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia	69
Risks of "blind" automated identification systems in medical microbiology	68
IFCC interim guidelines on molecular testing of SARS-CoV-2 infection	68
Microbiome markers are early predictors of acute GvHD in allogeneic hematopoietic stem cell transplant recipients	68
Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases?	67
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death	67
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects	62
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection	62
Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies	62
Characterization of four major human B-cell epitopes on the surface of HCV E2 glycoprotein by generation of human monoclonal Fab from phage display antibody librariesis	61
Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis Virus/HCV pseudotype	61
HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role	60
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity	60
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines	58
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab	58
Role and potential therapeutic use of antibodies against herpetic infections	55
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle	54
Modulation of epitope-specific anti-hepatitis C virus E2 (Anti-HCV/E2) antibodies by anti-viral treatment	54
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge	53
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy	52
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection	51
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site on gp120SITE ON GP120	50
Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugs	48
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin	48
Human Monoclonal Antibody able to nneutralize a broad range of H1 and H3 subtype influenza A viruses	47
IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients	46
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room	46
Microbiological Diagnosis of Sepsis: The Confounding Effects of a “Gold Standard”	44
Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial	44
Nanosphere's Verigene (R) System to detect Multidrug-Resistant Gram-negative Bacterial Outbreak: a prospective study in 60 patients	43
Molecular dissection of the IGM/K antibody repertoire in an HCV-infected patient with cryoglobulinemia	42
Longitudinal microbiome profile associates with the risk of major transplant-related complications in allogeneic HSCT recipients	42
Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System	40
Rapid Molecular Detection of Pathogens in 516 Consecutive Haematological Patients with Febrile Neutropenia	40
Rational dosing strategies of colistin: what about resistance?	38
Evaluation of a synergistic interactions of anti-E2/HCV monoclonal antibodies	38
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients	38
Molecular Cloning of a Human Monoclonal Antibody neutralizing a broad range of H1 subtype influenza virus including swine-origin influenza virus (S-OIV)	37
Molecular dissection of the human humoral response against HCV E2 glycoprotein by cloning of the antibody repertoire in phage display combinatorial vectors	37
Oral and Fecal Microbiota in Lynch Syndrome	36
Definition of biological activity and quantitation of different families of human anti-HCV/E2 antibodies by generation of human recombinant anti-E2 monoclonal Fab by phage display combinatorial repertoire library	36
RAPID MOLECULAR DETECTION OF PATHOGENS IN 1941 BLOOD SAMPLES FROM 516 CONSECUTIVE PATIENTS WITH FEBRILE NEUTROPENIA	33
Multiplex PCR-based assay (SeptiFast) for rapid detection of pathogens in febrile neutropenia: results in 273 consecutive patients	29
Molecular Diagnosis of Scedosporium apiospermum Keratitis	29
Totale	5.562

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	30.192
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	30.192

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	232	0	0	0	0	0	0	0	0	123	71	20	18
2023/2024	1.288	163	195	164	256	300	87	7	25	35	35	9	12
2024/2025	1.248	9	38	262	62	46	68	55	57	155	75	92	329
2025/2026	2.794	288	168	156	390	203	125	717	157	433	157	0	0
Totale													5.562